Abstract
Background The COVID-19 RT-PCR confirmed cases could be symptomatic or asymptomatic. In the United Arab Emirates (UAE), the identified COVID-19 RT-PCR confirmed cases are yet to be characterized. In this study, we characterized the first cohort of COVID-19 RT-PCR confirmed cases reported in the Abu Dhabi Emirate, UAE, according to symptomatic state, and identified factors associated with the symptomatic state. Also, the strength of association between the symptomatic state and testing positive in three subsequent RT-PCR testing rounds was examined and quantified.
Method We analyzed data collected from the first cohort of the RT-PCR confirmed COVID-19 cases reported to the health authorities in the Abu Dhabi Emirate – UAE between February 28 and April 08, 2020. Self-reported sociodemographic, working status, travel history, and chronic comorbidities of 1,249 COVID-19 cases were analyzed according to symptomatic state (symptomatic and asymptomatic). After the first RT-PCR confirmatory test, the results of three subsequent testing rounds were also analyzed.
Results A total of 791 confirmed cases with a mean age of 35.6 years±12.7 (range: 1-81 years) and information on symptomatic state were analyzed. Nearly, 56.0% were asymptomatic cases. The most frequent two symptoms were fever (58.0%) and cough (41.0%). The mean age of symptomatic (36.3 year ±12.6SD) was significantly higher than that of asymptomatic cases (34.5 year ±12.7SD). Compared to non-working populations, working in public places (aOR, 1.76, 95% CI: 1.11–2.80), healthcare settings (aOR, 2.09, 95% CI: 1.01–4.31), or in aviation and tourism sector (aOR, 2.24, 95% CI: 1.14–4.40), were independently associated with symptomatic state. Reporting at least one chronic comorbidity was also associated with symptomatic cases (aOR, 1.76, 5% CI: 1.03-3.01). Compared to asymptomatic, symptomatic COVID-19 cases had consistent odds of two or more of testing positive to COVID-19 in three subsequent testing rounds.
Conclusions A substantial proportion of the diagnosed COVID-19 cases in the Abu Dhabi Emirate was asymptomatic. Quarantine of asymptomatic cases along with prevention measures and raising awareness of populations working in high-risk settings is warranted. Further follow up research is needed to understand viral clearance and clinical outcomes according to the symptomatic state of the COVID-19 cases.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
This work received no specific fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Abu Dhabi Health COVID-19 Research Ethics Committee (IRB DOH/CVDC/2020/1518). Owing to the retrospective analysis nature of the study, patient informed consent was waived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Upon justifiable requests along with a permission from the IRB committee, dataset is available from the corresponding author Dr. Rami H. Al-Rifai (rrifai{at}uaeu.ac.ae).
